Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes
- PMID: 34580712
- PMCID: PMC8617310
- DOI: 10.1242/dmm.048953
Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes
Abstract
Oncogenic Ras mutations are highly prevalent in hematopoietic malignancies. However, it is difficult to directly target oncogenic RAS proteins for therapeutic intervention. We have developed a Drosophila acute myeloid leukemia model induced by human KRASG12V, which exhibits a dramatic increase in myeloid-like leukemia cells. We performed both genetic and drug screens using this model. The genetic screen identified 24 candidate genes able to attenuate the oncogenic RAS-induced phenotype, including two key hypoxia pathway genes HIF1A and ARNT (HIF1B). The drug screen revealed that echinomycin, an inhibitor of HIF1A, can effectively attenuate the leukemia phenotype caused by KRASG12V. Furthermore, we showed that echinomycin treatment can effectively suppress oncogenic RAS-driven leukemia cell proliferation, using both human leukemia cell lines and a mouse xenograft model. These data suggest that inhibiting the hypoxia pathway could be an effective treatment approach and that echinomycin is a promising targeted drug to attenuate oncogenic RAS-induced cancer phenotypes. This article has an associated First Person interview with the first author of the paper.
Keywords: Drosophila; Echinomycin; HIF1A; Hypoxia pathway; Leukemia; Mouse xenografts; Oncogenic RAS.
© 2021. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interests The authors declare no competing or financial interests.
Figures
Similar articles
-
HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.J Transl Med. 2017 Feb 10;15(1):28. doi: 10.1186/s12967-017-1132-9. J Transl Med. 2017. PMID: 28183349 Free PMC article.
-
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.Oncogene. 2020 Apr;39(14):3015-3027. doi: 10.1038/s41388-020-1201-z. Epub 2020 Feb 15. Oncogene. 2020. PMID: 32060420 Free PMC article.
-
The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.J Exp Clin Cancer Res. 2021 Sep 1;40(1):278. doi: 10.1186/s13046-021-02082-7. J Exp Clin Cancer Res. 2021. PMID: 34470658 Free PMC article.
-
Targeting Ras signaling in AML: RALB is a small GTPase with big potential.Small GTPases. 2020 Jan;11(1):39-44. doi: 10.1080/21541248.2017.1339765. Epub 2017 Jul 7. Small GTPases. 2020. PMID: 28682649 Free PMC article. Review.
-
Targeting oncogenic Ras signaling in hematologic malignancies.Blood. 2012 Oct 25;120(17):3397-406. doi: 10.1182/blood-2012-05-378596. Epub 2012 Aug 16. Blood. 2012. PMID: 22898602 Free PMC article. Review.
Cited by
-
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.Int J Mol Sci. 2023 Feb 23;24(5):4430. doi: 10.3390/ijms24054430. Int J Mol Sci. 2023. PMID: 36901857 Free PMC article. Review.
-
Using Drosophila Nephrocytes to Understand the Formation and Maintenance of the Podocyte Slit Diaphragm.Front Cell Dev Biol. 2022 Feb 21;10:837828. doi: 10.3389/fcell.2022.837828. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35265622 Free PMC article. Review.
-
First person - Jun-yi Zhu and Xiaohu Huang.Dis Model Mech. 2022 Feb 1;15(2):dmm049329. doi: 10.1242/dmm.049329. Epub 2021 Nov 19. Dis Model Mech. 2022. PMID: 34797366 Free PMC article.
-
The Roles of Histone Lysine Methyltransferases in Heart Development and Disease.J Cardiovasc Dev Dis. 2023 Jul 18;10(7):305. doi: 10.3390/jcdd10070305. J Cardiovasc Dev Dis. 2023. PMID: 37504561 Free PMC article. Review.
-
Understanding and drugging RAS: 40 years to break the tip of the iceberg.Dis Model Mech. 2022 Feb 1;15(2):dmm049519. doi: 10.1242/dmm.049519. Epub 2022 Mar 4. Dis Model Mech. 2022. PMID: 35244677 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
